CGT (細胞・遺伝子治療) ツールおよび試薬：世界市場

世界のCGT (細胞・遺伝子治療) ツールおよび試薬の市場規模は、2024年の100億米ドルから、予測期間中は10.8%のCAGRで推移し、2029年には167億米ドルに達すると予測されています。

北米市場は、2024年の46億米ドルから、CAGR 12.1%で推移し、2029年には82億米ドルに達すると予測されています。欧州市場は、2024年の26億米ドルから、CAGR 10.5%で推移し、2029年には43億米ドルに達すると予測されています。

当レポートでは、世界のCGT (細胞・遺伝子治療) ツールおよび試薬の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場の展望
• 調査範囲
• 市場概要

第2章 市場概要

• 概要
• 技術的背景：細胞治療
• 細胞療法の種類
• 技術的背景：遺伝子治療
• 遺伝子治療の種類
• 承認されたCGT製品

第3章 市場力学

• 市場力学
• 市場促進要因
• CGT研究への投資
• 臨床および商業製造能力の拡大
• 慢性疾患の発生率の増加
• コラボレーションと買収
• 市場抑制要因
• 製造とサプライチェーンの複雑性
• 熟練した人材の不足
• 市場機会
• CGT技術の進歩の活用
• 規制状況
• 遺伝子治療規制
• 細胞治療規制
• ウイルスベクターと非ウイルスベクター
• 培地
• GMPタンパク質と抗体
• 白血球除去療法
• 欧州のキャピタルゲイン税規制

第4章 新興技術と開発

• クローズドシステムと自動化システム
• シングルユース技術

第5章 市場セグメンテーション分析

• 市場動向
• セグメンテーションの内訳
• 世界のCGTツールおよび試薬市場：製品別
• 免疫測定
• バイオリアクター
• 白血球除去療法
• GMP抗体
• マルチプレックス免疫測定
• ベクター
• 細胞分離
• 凍結保存
• 細胞増殖
• 培地
• GMPタンパク質
• GMP小分子
• CRSモニタリング
• 世界のCGTツールおよび試薬市場：用途別
• がん
• 希少疾患
• その他の病気
• 世界のCGTツールおよび試薬市場：エンドユーザー別
• 製薬・バイオテクノロジー企業
• 学術研究機関
• 臨床ラボ
• 地理的内訳
• 世界のCGTツールおよび試薬市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情報

• 主要企業のランキング
• 主要企業の戦略
• 製品発売
• コラボレーション・パートナーシップ
• 拡張
• 合意
• 買収
• その他

第7章 CGTツールおよび試薬市場における持続可能性：ESGの観点

• ESG：イントロダクション
• 業界におけるESGパフォーマンス
• CGTツールおよび試薬業界におけるESGの実践
• 環境パフォーマンス
• BCCからの総論

第8章 付録

• 調査手法
• 略語
• 参考文献
• 企業プロファイル
• ABCAM LTD.
• ADVERUM BIOTECHNOLOGIES INC.
• AKRON BIOTECH
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• CYTIVA
• FUJIFILM IRVINE SCIENTIFIC
• MILTENYI BIOTEC
• PROTEINTECH GROUP INC.
• QIAGEN
• REVVITY
• SARTORIUS CELLGENIX GMBH
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table A : Global Market for CGT Tools and Reagents, by Application, Through 2029
• Summary Table B : Global Market for CGT Tools and Reagents, by Region, Through 2029
• Table 1 : Approved CGT Products, as of 2024
• Table 2 : Global Cancer Statistics, 2022
• Table 3 : Global Market for CGT Tools and Reagents, by Product, Through 2029
• Table 4 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, Through 2029
• Table 5 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, Through 2029
• Table 6 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, Through 2029
• Table 7 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, Through 2029
• Table 8 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, Through 2029
• Table 9 : Global Market for CGT Tools and Reagents for Vectors, by Region, Through 2029
• Table 10 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, Through 2029
• Table 11 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, Through 2029
• Table 12 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, Through 2029
• Table 13 : Global Market for CGT Tools and Reagents for Media, by Region, Through 2029
• Table 14 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, Through 2029
• Table 15 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, Through 2029
• Table 16 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, Through 2029
• Table 17 : Global Market for CGT Tools and Reagents, by Application, Through 2029
• Table 18 : Global Market for CGT Tools and Reagents for Cancer, by Region, Through 2029
• Table 19 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, Through 2029
• Table 20 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, Through 2029
• Table 21 : Global Market for CGT Tools and Reagents, by End User, Through 2029
• Table 22 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, Through 2029
• Table 23 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, Through 2029
• Table 24 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, Through 2029
• Table 25 : Global Market for CGT Tools and Reagents, by Region, Through 2029
• Table 26 : North American Market for CGT Tools and Reagents, by Product, Through 2029
• Table 27 : North American Market for CGT Tools and Reagents, by Application, Through 2029
• Table 28 : North American Market for CGT Tools and Reagents, by End User, Through 2029
• Table 29 : European Research Initiatives Focused on Personalized Medicine
• Table 30 : European Market for CGT Tools and Reagents, by Product, Through 2029
• Table 31 : European Market for CGT Tools and Reagents, by Application, Through 2029
• Table 32 : European Market for CGT Tools and Reagents, by End User, Through 2029
• Table 33 : Asia-Pacific Market for CGT Tools and Reagents, by Product, Through 2029
• Table 34 : Asia-Pacific Market for CGT Tools and Reagents, by Application, Through 2029
• Table 35 : Asia-Pacific Market for CGT Tools and Reagents, by End User, Through 2029
• Table 36 : RoW Market for CGT Tools and Reagents, by Product, Through 2029
• Table 37 : RoW Market for CGT Tools and Reagents, by Application, Through 2029
• Table 38 : RoW Market for CGT Tools and Reagents, by End User, Through 2029
• Table 39 : Leading Companies in the CGT Tool and Reagent Market, 2023
• Table 40 : Product Launches in the Market for CGT Tools and Reagents, 2021-2024
• Table 41 : Collaborations and Partnerships in the CGT Tool and Reagent Market, 2022-2024
• Table 42 : Expansions in the Market for CGT Tools and Reagents, 2022-2024
• Table 43 : Agreements in the Market for CGT Tools and Reagents, 2022-2024
• Table 44 : Acquisitions in the CGT Market for Tools and Reagents, 2022-2024
• Table 45 : Other Developments in the Market for CGT Tools and Reagents, 2023 and 2024
• Table 46 : Focus Areas in ESG Metrics
• Table 47 : Environmental Performance Initiatives in the CGT Tool and Reagent Market
• Table 48 : Social Performance Initiatives in the CGT Tool and Reagent Market
• Table 49 : Governance Performance Initiatives in the CGT Tool and Reagent Market
• Table 50 : ESG Rankings for Leaders in the Market for CGT Tools and Reagents, 2024*
• Table 51 : Abbreviations Used in this Report
• Table 52 : Abcam Ltd.: Company Snapshot
• Table 53 : Abcam Ltd.: Financial Performance, FY 2022 and 2023
• Table 54 : Abcam Ltd.: Product Portfolio
• Table 55 : Abcam Ltd.: News/Key Developments, 2022 and 2023
• Table 56 : Adverum Biotechnologies Inc.: Company Snapshot
• Table 57 : Adverum Biotechnologies Inc.: Financial Performance, FY 2022 and 2023
• Table 58 : Adverum Biotechnologies Inc.: Product Portfolio
• Table 59 : Adverum Biotechnologies Inc.: News/Key Developments, 2022-2024
• Table 60 : Akron Biotech: Company Snapshot
• Table 61 : Akron Biotech: Product Portfolio
• Table 62 : Akron Biotech: News/Key Developments, 2022-2024
• Table 63 : Bio-Rad Laboratories Inc.: Company Snapshot
• Table 64 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
• Table 65 : Bio-Rad Laboratories Inc.: Product Portfolio
• Table 66 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
• Table 67 : Bio-Techne: Company Snapshot
• Table 68 : Bio-Techne: Financial Performance, FY 2022 and 2023
• Table 69 : Bio-Techne: Product Portfolio
• Table 70 : Bio-Techne: News/Key Developments, 2023 and 2024
• Table 71 : Cytiva: Company Snapshot
• Table 72 : Cytiva: Product Portfolio
• Table 73 : Cytiva: News/Key Developments, 2023 and 2024
• Table 74 : FUJIFILM Irvine Scientific: Company Snapshot
• Table 75 : FUJIFILM Irvine Scientific: Product Portfolio
• Table 76 : FUJIFILM Irvine Scientific: News/Key Developments, 2022 and 2023
• Table 77 : Miltenyi Biotec: Company Snapshot
• Table 78 : Miltenyi Biotec: Product Portfolio
• Table 79 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
• Table 80 : Proteintech Group Inc.: Company Snapshot
• Table 81 : Proteintech Group Inc.: Product Portfolio
• Table 82 : QIAGEN: Company Snapshot
• Table 83 : QIAGEN: Financial Performance, FY 2022 and 2023
• Table 84 : QIAGEN: Product Portfolio
• Table 85 : QIAGEN: News/Key Developments, 2022-2024
• Table 86 : Revvity: Company Snapshot
• Table 87 : Revvity: Financial Performance, FY 2022 and 2023
• Table 88 : Revvity: Product/Solutions Portfolio
• Table 89 : Revvity: News/Key Developments, 2023 and 2024
• Table 90 : Sartorius CellGenix GmbH: Company Snapshot
• Table 91 : Sartorius CellGenix GmbH: Product Portfolio
• Table 92 : Sartorius CellGenix GmbH: News/Key Developments, 2023 and 2024
• Table 93 : STEMCELL Technologies: Company Snapshot
• Table 94 : STEMCELL Technologies: Product Portfolio
• Table 95 : STEMCELL Technologies: News/Key Developments, 2022-2024
• Table 96 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 97 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 98 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 99 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023

List of Figures

• Summary Figure A : Global Market for CGT Tools and Reagents, by Application, 2021-2029
• Summary Figure B : Global Market for CGT Tools and Reagents, by Region, 2021-2029
• Figure 1 : Market Dynamics of CGT Tools and Reagents
• Figure 2 : CGT Sector Investments, 2018-2023
• Figure 3 : CGT Sector Investments, by Deal Type, Q1 2024
• Figure 4 : Global Market Shares of CGT Tools and Reagents, by Product, 2024
• Figure 5 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, 2021-2029
• Figure 6 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, 2021-2029
• Figure 7 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, 2021-2029
• Figure 8 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, 2021-2029
• Figure 9 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, 2021-2029
• Figure 10 : Global Market Shares of Gene Therapy Clinical Trials, by Vector Type, 2022
• Figure 11 : Global Market for CGT Tools and Reagents for Vectors, by Region, 2021-2029
• Figure 12 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, 2021-2029
• Figure 13 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, 2021-2029
• Figure 14 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, 2021-2029
• Figure 15 : Global Market for CGT Tools and Reagents for Media, by Region, 2021-2029
• Figure 16 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, 2021-2029
• Figure 17 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, 2021-2029
• Figure 18 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, 2021-2029
• Figure 19 : Global Market Shares of CGT Tools and Reagents, by Application, 2024
• Figure 20 : Global Market for CGT Tools and Reagents for Cancer, by Region, 2021-2029
• Figure 21 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, 2021-2029
• Figure 22 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, 2021-2029
• Figure 23 : Global Market Shares of CGT Tools and Reagents, by End User, 2024
• Figure 24 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, 2021-2029
• Figure 25 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, 2021-2029
• Figure 26 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, 2021-2029
• Figure 27 : Global Market Shares of CGT Tools and Reagents, by Region, 2024
• Figure 28 : North American Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 29 : North American Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 30 : North American Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 31 : European Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 32 : European Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 33 : European Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 34 : Asia-Pacific Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 35 : Asia-Pacific Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 36 : Asia-Pacific Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 37 : RoW Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 38 : RoW Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 39 : RoW Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 40 : How a Strong ESG Proposition Benefits Businesses
• Figure 41 : Abcam Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 42 : Abcam Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 43 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 44 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 45 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
• Figure 46 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
• Figure 47 : QIAGEN: Revenue Share, by Business Unit, FY 2023
• Figure 48 : QIAGEN: Revenue Share, by Country/Region, FY 2023
• Figure 49 : Revvity: Revenue Share, by Business Unit, FY 2023
• Figure 50 : Revvity: Revenue Share, by Country/Region, FY 2023
• Figure 51 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 52 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

The North American market for CGT Tools and Reagents is estimated to increase from $4.6 billion in 2024 to reach $8.2 billion by 2029, at a CAGR of 12.1% from 2024 through 2029.

The European market for CGT Tools and Reagents is estimated to increase from $2.6 billion in 2024 to reach $4.3 billion by 2029, at a CAGR of 10.5% from 2024 through 2029.

Report Scope

This report analyzes the global market for cell and gene therapy tools and reagents. The market is segmented by product type, disease or application, end user and region. Product types include gene vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome monitoring, cryopreservation reagents, and solutions and media. Diseases or applications include cancer and rare diseases. End users include pharmaceutical and biotech companies, academic research institutes, and clinical laboratories. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

This report also examines strategies and collaborations, discusses the regulatory landscape, and analyzes macroeconomic factors when considering new technologies, the industry's increasing competitiveness, and emerging customer needs. This report also examines analytical frameworks, such as ESG analysis, patent analysis, competitive analysis, and strategic recommendations, which will aid companies in devising their strategic plans.

Report Includes

• 44 data tables and 57 additional tables
• An update on the global market for cell and gene therapy tools and reagents
• Analyses of the global market trends, with historic market revenue for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• A look at the market potential for the cell and gene therapy tools and reagents in the life sciences industry, market drivers, and forecasts for the market segments of product, application, end user and region
• Facts and figures pertaining to major market dynamics, product innovations, clinical trials, and government regulations
• Review of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
• Coverage of the technological, economic and business considerations of the market, and the vendor landscape
• Analysis of the industry's regulatory framework and policies, and product pipeline
• Discussion of ESG challenges and ESG practices in the industry
• Market share analysis of the key companies in the industry and coverage of their proprietary technologies and strategies
• Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Sartorius CellGenix GmbH, and Miltenyi Biotec

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Technology Background: Cell Therapy
• Types of Cell Therapy
• Technology Background: Gene Therapy
• Types of Gene Therapy
• Approved CGT Products

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Investments in CGT Research
• Capacity Expansions for Clinical and Commercial Manufacturing
• Increasing Incidence of Chronic Diseases
• Collaborations and Acquisitions
• Market Restraints
• Complexity in Manufacturing and Supply Chain
• Lack of Skilled Force
• Market Opportunities
• Harnessing the Advances in CGT Technologies
• Regulatory Landscape
• Gene Therapy Regulations
• Cell Therapy Regulations
• Viral and Non-Viral Vectors
• Media
• GMP Proteins and Antibodies
• Leukapheresis
• CGT Regulations in Europe

Chapter 4 Emerging Technologies and Developments

• Closed and Automated Systems
• Single-Use Technologies

Chapter 5 Market Segmentation Analysis

• Market Trends
• Segmentation Breakdown
• Global Market for CGT Tools and Reagents, by Product
• Immunoassays
• Bioreactors
• Leukapheresis
• GMP Antibodies
• Multiplex Immunoassays
• Vectors
• Cell Separation
• Cryopreservation
• Cell Expansion
• Media
• GMP Proteins
• GMP Small Molecules
• CRS Monitoring
• Global Market for CGT Tools and Reagents, by Application
• Cancer
• Rare Diseases
• Other Diseases
• Global Market for CGT Tools and Reagents, by End User
• Pharmaceutical and Biotech Companies
• Academic and Research Institutes
• Clinical Laboratories
• Geographic Breakdown
• Global Market for CGT Tools and Reagents, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Ranking of Leading Players
• Strategies of Leading Companies
• Product Launches
• Collaborations and Partnerships
• Expansions
• Agreements
• Acquisitions
• Others

Chapter 7 Sustainability in the CGT Tool and Reagent Market: ESG Perspective

• Introduction to ESG
• ESG Performance in the Industry
• ESG Practices in the CGT Tool and Reagent Industry
• Environmental Performance
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Methodology
• Abbreviations
• References
• Company Profiles
• ABCAM LTD.
• ADVERUM BIOTECHNOLOGIES INC.
• AKRON BIOTECH
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• CYTIVA
• FUJIFILM IRVINE SCIENTIFIC
• MILTENYI BIOTEC
• PROTEINTECH GROUP INC.
• QIAGEN
• REVVITY
• SARTORIUS CELLGENIX GMBH
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.